...
首页> 外文期刊>Marmara Medical Journal >Comparison of Fixed 10 mCi and 15 mCi Iodine-131 Doses for the Treatment of Graves' Disease: 11 Year Study
【24h】

Comparison of Fixed 10 mCi and 15 mCi Iodine-131 Doses for the Treatment of Graves' Disease: 11 Year Study

机译:固定10 mCi和15 mCi碘131剂量治疗格雷夫斯病的比较:11年研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives: Fixed dose Iodine-131 (RAI) treatment is a simple method which does not obviate sophisticated calculations. In this study, we compared the results of fixed 10mCi and 15 mCi RAI treatment.Patients and Methods: In this study we included 55 patients who received fixed 10 mCi and 15 mCi RAI treatment between 1997-2008 years and were followed for at least 2 years. Then we analyzed the results as successful (euthyroid, hypothyroid) and unsuccessful (persistant hyperthyroid) treatment rates and other parameters that could have affected the results. Results: The success rate in patients who received 10 mCi RAI was 87% (euthyroid 9.1%, hypothyroid 78.2%). The success rate in patients who received 15 mCi RAI was 100% (hypothyroid). There is no statistically significant difference between these groups except mean propythiouracil doses (10 mCi: 190 mg, 15 mCi: 350 mg, p <0.05). Conclusion: Fixed 10 mCi and 15 mCi RAI dose applications were both successful in the treatment of Graves' disease. Albeit at a lower rate persistent hyperthyroidism can be seen in patients given fixed 10 mCi RAI dose.
机译:目的:固定剂量的碘131(RAI)治疗是一种简单的方法,不会消除复杂的计算。在这项研究中,我们比较了固定10mCi和15 mCi RAI治疗的结果。患者和方法:在本研究中,我们纳入了55例1997-2008年间接受固定10 mCi和15 mCi RAI治疗的患者,并至少随访2年份。然后,我们分析了成功率(甲状腺功能正常,甲状腺功能减退)和失败率(持续甲状腺功能亢进)的治疗结果以及可能影响结果的其他参数。结果:接受10 mCi RAI的患者成功率为87%(甲状腺功能正常9.1%,甲状腺功能减退78.2%)。接受15 mCi RAI的患者成功率为100%(甲状腺功能减退)。除了丙硫氧嘧啶的平均剂量(10 mCi:190 mg,15 mCi:350 mg,p <0.05)外,这些组之间没有统计学上的显着差异。结论:固定的10 mCi和15 mCi的RAI剂量均可成功治疗Graves病。给予固定的10 mCi RAI剂量的患者可以观察到持续性甲亢的发生率较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号